Long-term survival benefit for metastatic melanoma patients treated with Dabrafenib plus Trametinib
The results from COMBI-d and COMBI-v clinical trials were presented at the 2019 American Society of Clinical Oncology ( ASCO ) Annual Meeting and published simultaneously in The New England Journal of ...
read article